about
Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of InfectionInteraction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptorPrinciples of Virus Uncoating: Cues and the Snooker BallCell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interactionAdenovirus vector designed for expression of toxic proteins.Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells.Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains.The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptorBiodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice.The coxsackie B virus and adenovirus receptor resides in a distinct membrane microdomain.Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells.Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomicsGene transfer approaches for the treatment of inflammatory bowel disease.Recombination of the epsilon determinant and corneal tropism: Human adenovirus species D types 15, 29, 56, and 69.A mouse model for adenovirus gene delivery.Host cell autophagy modulates early stages of adenovirus infections in airway epithelial cells.Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.Influenza virus entry and infection require host cell N-linked glycoprotein.Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.Dynamics of virus-receptor interactions in virus binding, signaling, and endocytosisAdenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum.Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.Guiding plant virus particles to integrin-displaying cellsLysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome.Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature.Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD.The Coxsackie and adenovirus receptor binds microtubules and plays a role in cell migration.Enhanced gene transfer activity of peptide-targeted gene-delivery vectors.Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IXThe cationic amphipathic alpha-helix of HIV-1 viral protein R (Vpr) binds to nucleic acids, permeabilizes membranes, and efficiently transfects cells.Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleusInduction of cyclo-oxygenase-2 in non-small cell lung cancer cells by infection with DeltaE1, DeltaE3 recombinant adenovirus vectors.Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes.Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entryN-terminal α-helix-independent membrane interactions facilitate adenovirus protein VI induction of membrane tubule formation.
P2860
Q27487405-F66094C7-5EA6-43FE-A104-28DF72862112Q27635031-AD73F423-6005-4610-A2FF-21F2D304415CQ28074854-22461FF4-6A30-4524-8973-34B231D46CBAQ28744246-C05B7DE6-0F58-4875-AF17-D865DAAA8B12Q30719733-EE136AE6-1A6B-4A69-83DE-545486D60742Q33275292-4147D35A-C1D6-42FE-A0EA-7AC2745E7031Q34150166-60A9ED47-8720-463B-8CB7-57BB040CA23BQ34170231-BD5B6217-D776-4E83-8793-EA41DC9C862DQ34194285-CC451E18-CD03-4756-B492-D840C497E4D9Q34471404-A4CF444D-FD1A-45BE-A108-63F6FE9B5842Q34990401-985A7458-0DD4-42D8-BDEC-DEF281E6B383Q35109904-96EC464A-FC97-418D-A029-714BDA570EB1Q35122162-0F11616A-74A0-43CE-9080-0A04BFA3F59EQ36202765-AED7E8F3-311A-498F-AB51-DAB3FFC446C4Q36529815-36B8DABB-4067-44A8-B298-45F4A4D1F1DDQ36607369-A6366237-2653-4928-8717-B11325A76D7EQ37615161-6A3F738E-1305-4440-9FF0-CB7E211FDD58Q37647530-A0B36BE3-98DB-481D-BA22-8E8777BF7DECQ37710991-27BF3DBB-2C06-4C86-8B7A-8688E741769BQ37713831-ECF10D9E-5776-4A23-866B-36B9414BD1B9Q38515936-7EA56740-CC89-42A9-922C-1D6116D72D52Q38721817-01F2D398-AF52-49BD-97D2-45ADC31FDA78Q39093893-FC341939-0935-4C00-8EE9-FDA03E8D0C74Q39348354-43857C63-EBBF-4BFC-9BE4-45B40A7B89E4Q39593763-B61235B3-1C41-47B4-86D9-F77D70B90160Q39682554-77B87C98-15E9-4042-AE60-4A6BE6A08A58Q39686069-ACB87C02-9392-4785-B240-B066ACA7F227Q39712319-8EC64518-C2E7-4DB6-A155-F5793DD38A83Q40126105-0EA39E08-808D-4FA4-B928-D48AD6144A72Q40185489-2CCCC120-5338-445A-916C-D4BBC8041769Q40431364-1FC22CAB-949A-4417-8D92-B1EBA615E040Q40579221-E3CB66AD-4EA4-457A-A61B-00BE827E5C0DQ40663632-93899C25-F3F3-40E5-9717-AD674909E45EQ40721382-CB3C23B4-9E70-4165-A24C-CE3E0222D19FQ40750297-0175DB19-5D09-4B9A-A8DA-844A18F44FF6Q41610747-6CAD5E5D-900A-4CD7-BBF2-1A2A1D2023D4Q41847338-209AA789-8C8E-4239-886D-B898D74E38FCQ42016952-A299DB94-2E5D-4DC6-8EF0-C1FAD64496E0Q42051675-3E3CACD5-D08A-4BEE-8F7F-3BC5ACFA7378Q42716119-BF2725CE-41C8-4A73-9D8D-7BB43E9081D9
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cell receptors involved in adenovirus entry.
@ast
Cell receptors involved in adenovirus entry.
@en
type
label
Cell receptors involved in adenovirus entry.
@ast
Cell receptors involved in adenovirus entry.
@en
prefLabel
Cell receptors involved in adenovirus entry.
@ast
Cell receptors involved in adenovirus entry.
@en
P356
P1433
P1476
Cell receptors involved in adenovirus entry.
@en
P2093
Nemerow GR
P356
10.1006/VIRO.2000.0468
P407
P577
2000-08-01T00:00:00Z